[Federal Register Volume 72, Number 95 (Thursday, May 17, 2007)]
[Notices]
[Page 27801]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-9539]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[Docket T-3-2007]


Foreign-Trade Zone 7 - - Mayaguez, Puerto Rico, Application for 
Temporary/Interim Manufacturing Authority, Merck Sharpe & Dohme Quimica 
De Puerto Rico, Inc., (Pharmaceutical Products), Caguas, Puerto Rico

    An application has been submitted to the Executive Secretary of the 
Foreign-Trade Zones Board (the Board) by the Puerto Rico Industrial 
Development Company (PRIDCO), grantee of FTZ 7, requesting temporary/
interim manufacturing (T/IM) authority within FTZ 7 at the MOVA 
Pharmaceutical Corporation (MOVA) facility in Caguas, Puerto Rico, on 
behalf of Merck Sharp & Dohme Quimica De Puerto Rico, Inc. (MSDQ). The 
application was filed on May 10, 2007.
    The MOVA facility (650 employees, 250,000 sq. ft.) is located at 
State Road 1, Km 34.8, within the Villa Blanca Industrial Park in 
Caguas (Site 1, Parcel 2). T/IM procedures would be used for 
pharmaceutical manufacturing involving two products, MK-431A and 
sitagliptin (HTSUS 3004.90 and 2933.59) on behalf of MSDQ for the U.S. 
market and export. Foreign components that would be used in the 
manufacturing process (up to 25[percnt] of total content) include 
sitagliptin, metformin hydrochloride, enamine amide and butyl josphos 
(duty rates of 3.7 to 6.5[percnt]). MSDQ has also submitted a request 
for permanent FTZ manufacturing authority (which will be docketed with 
the Board separately).
    FTZ procedures would exempt MSDQ from Customs duty payments on 
foreign components used in production for export to non-NAFTA 
countries. For domestic and NAFTA markets, MSDQ could select the duty 
rate that applies to the finished product (duty-free to 6.5[percnt]) 
for the components used in production when the finished products are 
entered for U.S. consumption from the zone. The application indicates 
that the company would also realize duty deferral and certain 
logistical/supply chain savings.
    Public comment is invited from interested parties. Submissions 
(original and 3 copies) shall be addressed to the Board's Executive 
Secretary at the following address: Office of the Executive Secretary, 
Room 2111, U.S. Department of Commerce, 1401 Constitution Avenue, NW., 
Washington, DC 20230. The closing period for receipt of comments is 
June 18, 2007.
    A copy of the application will be available for public inspection 
at the Office of the Foreign-Trade Zones Board's Executive Secretary at 
the address listed above. For further information, contact Christopher 
Kemp at: [email protected], or (202) 482-0862.

    Dated: May 10, 2007.
Andrew McGilvray,
Executive Secretary.
[FR Doc. E7-9539 Filed 5-16-07; 8:45 am]
BILLING CODE 3510-DS-S